Author Profile
Herpfer, Christoph
Reversing Sickle Cell Disease: A Crisp Deal?
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1795 | Published November 12, 2025 | 11 Pages Case
Collection: Darden School of Business
Carmen Jones, principal at a venture capital firm in the biotechnology industry, pondered the latest deal the firm was considering. It had recently closed a $700 million fund and was evaluating severa... Read More
Stroke-of-Pen Risk and Vantage Oncology, LLC
Herpfer, Christoph; Adkins, Thomas
F-2128 | Published October 21, 2025 | 14 Pages Case
Collection: Darden School of Business
In July 2013, Mike Fiore, CEO and cofounder of Vantage Oncology, LLC (Vantage), a developer and operator of freestanding radiation oncology centers, learned that the Centers for Medicare & Medicaid Se... Read More
Physician Fee Schedule: A Primer
Herpfer, Christoph; Adkins, Thomas
F-2129 | Published October 21, 2025 | 4 Pages Technical Note
Collection: Darden School of Business
This technical note provides an overview of the Centers for Medicare & Medicaid Services (CMS) physician fee schedule (PFS), which governs payment rates for physicians and health care providers under ... Read More
Venture Capital in Biotechnology
Matherne, G. (Paul); Herpfer, Christoph; Dow, Ethan
OM-1796 | Published December 05, 2023 | 8 pages Technical Note
Collection: Darden School of Business
Pharmaceutical companies have historically relied on their ability to research, develop, manufacture, and sell drug products. Developing a successful drug is a complex and lengthy process, with no gua... Read More